| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-7 Days |
| Number of Subjects | 110 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64, 65+ |
| Body Types | Overweight, Average |
In patients undergoing jaw surgery (removal of third molar), 30mg serrapeptase daily for up to a week was more effective than placebo in reducing pain and swelling although trismus (opening of the jaw) was unaffected.
